The COVID-19 has fostered a considerable rise in pharma-related research, simultaneously causing a surge in the volume of applications in this field. The last report<\/a> compiled by the European Patent Office states that in 2020, the number of pharmaceutical applications increased by 10.2% and was the fastest-growing technological area in the region.<\/p>\n Given the overall revival in pharmaceuticals, it would be interesting to discern the key players currently participating in the field’s patent activities. Therefore, the report further covers the following questions:<\/p>\n Note that the analysis and statistics presented in the current report rely on the patent representations data<\/a> compiled by IP Pilot<\/a> and the number of patent filings published between 2016 and January 2022.<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n
![\"Search,](\"https:\/\/www.ip-pilot.com\/wp-content\/uploads\/2022\/04\/Untitled-design-66-2.png\" "\\"Search,")
<\/span><\/div><\/div><\/div>